Actinomycin D inhibits human immunodeficiency virus type 1 minus-strand transfer in in vitro and endogenous reverse transcriptase assays

Journal of Virology

Volumn 72, Issue 8, 1998, Pages 6716-6724

  Guo, Jianhui ^a   Wu, Tiyun ^a   Bess, Julian ^b   Henderson, Louis E ^b   Levin, Judith G ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACTINOMYCIN; RNA DIRECTED DNA POLYMERASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; CATALYSIS; DNA DETERMINATION; DNA STRAND; DNA SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROVIRUS; RNA SYNTHESIS; VIRUS NUCLEOCAPSID;

EID: 0031926679     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.8.6716-6724.1998     Document Type: Article

References (77)

1. Adachi, A., H. E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Allain, B., M. Lapadat-Tapolsky, C. Berlioz, and J.-L. Darlix. 1994. Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome. EMBO J. 13:973-981.
3. Bader, J. P. 1964. The role of deoxyribonucleic acid in the synthesis of Rous sarcoma virus. Virology 22:462-468.
4. nT motif of double-stranded DNA: determination of the guanine requirement in nonclassical, non-GpC binding sites. Biochemistry 33:11493-11500.
5. Baltimore, D. 1970. RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature 226:1209-1211.
6. Bases, R. E., and A. S. King. 1967. Inhibition of Rauscher murine leukemia virus growth in vitro by actinomycin D. Virology 32:175-183.
7. Bertrand, E. L., and J. J. Rossi. 1994. Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1. EMBO J. 13:2904-2912.
8. Bunte, T., U. Novak, R. Friedrich, and K. Moelling. 1980. Effect of actinomycin D on nucleic acid hybridization: the cause of erroneous DNA elongation during DNA synthesis of RNA tumor viruses in vitro. Biochim. Biophys. Acta 610:241-247.
9. Busch, L. K. 1994. Production of HIV-1 (MN) nucleocapsid protein (p7) by recombinant DNA technology. M.S. thesis. Hood College, Frederick, Md.
10. Champoux, J. J. 1993. Roles of ribonuclease H in reverse transcription, p. 103-117. In A. M. Skalka and S. P. Goff (ed.), Reverse transcriptase. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y.
11. Chen, F.-M. 1988. Binding specificities of actinomycin D to self-complementary tetranucleotide sequences-XGCY-. Biochemistry 27:6393-6397.
12. Chen, M.-J., C. F. Garon, and T. S. Papas. 1980. Native ribonucleoprotein is an efficient transcriptional complex of avian myeloblastosis virus. Proc. Natl. Acad. Sci. USA 77:1296-1300.
13. Darlix, J.-L., M. Lapadat-Tapolsky, H. de Rocquigny, and B. P. Roques. 1995. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 254:523-537.
14. Debyser, Z., A.-M. Vandamme, R. Pauwels, M. Baba, J. Desmyter, and E. De Clercq. 1992. Kinetics of inhibition of endogenous human immunodeficiency virus type 1 reverse transcription by 2′,3′-dideoxynucleoside 5′-triphosphate, tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepin-2(1H)-thione, and 1-[(2-hydroxyethoxy) methyl]-6-(phenylthio)thymine derivatives. J. Biol. Chem. 267: 11769-11776.
15. De Guzman, R. N., Z. R. Wu, C. C. Stalling, L. Pappalardo, P. N. Borer, and M. F. Summers. 1998. Structure of the HIV-1 nucleocapsid protein bound to the SL3 ψ-RNA recognition element. Science 279:384-388.
16. DeStefano, J. J. 1995. Human immunodeficiency virus nucleocapsid protein stimulates strand transfer from internal regions of heteropolymeric RNA templates. Arch. Virol. 140:1775-1789.
17. Dib-Hajj, F., R. Khan, and D. P. Giedroc. 1993. Retroviral nucleocapsid proteins possess potent nucleic acid strand renaturation activity. Protein Sci. 2:231-243.
18. Duesberg, P. H., and W. S. Robinson. 1967. Inhibition of mouse leukemia virus (MLV) replication by actinomycin D. Virology 31:742-746.
19. Farber, S. 1966. Chemotherapy in the treatment of leukemia and Wilms' tumor. JAMA 198:826-836.
20. Feng, Y.-X., T. D. Copeland, L. E. Henderson, R. J. Gorelick, W. J. Bosche, J. G. Levin, and A. Rein. 1996. HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc. Natl. Acad. Sci. USA 93:7577-7581.
21. Fisher, R. J., A. Rein, M. Fivash, M. A. Urbaneja, J. R. Casas-Finet, M. Medaglia, and L. E. Henderson. 1998. Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides. J. Virol. 72:1902-1909.
22. Fleissner, E., and E. Tress. 1973. Isolation of a ribonucleoprotein structure from oncornaviruses. J. Virol. 12:1612-1615.
23. Furfine, E. S., and J. E. Reardon. 1991. Reverse transcriptase · RNase H from the human immunodeficiency virus. Relationship of the DNA polymerase and RNA hydrolysis activities. J. Biol. Chem. 266:406-412.
24. Gerwin, B. I., and J. G. Levin. 1977. Interactions of murine leukemia virus core components: characterization of reverse transcriptase packaged in the absence of 70S genomic RNA. J. Virol. 24:478-488.
25. Gilboa, E., S. W. Mitra, S. Goff, and D. Baltimore. 1979. A detailed model of reverse transcription and tests of crucial aspects. Cell 18:93-100.
26. Goodisman, J., R. Rehfuss, B. Ward, and J. C. Dabrowiak. 1992. Site-specific binding constants for actinomycin D on DNA determined from footprinting studies. Biochemistry 31:1046-1058.
27. Gopalakrishnan, V., J. A. Peliska, and S. J. Benkovic. 1992. Human immunodeficiency virus type 1 reverse transcriptase: spatial and temporal relationship between the polymerase and RNase H activities. Proc. Natl. Acad. Sci. USA 89:10763-10767.
28. Guo, J., L. E. Henderson, J. Bess, B. Kane, and J. G. Levin. 1997. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA. J. Virol. 71:5178-5188.
29. Guo, J., W. Wu, Z. Y. Yuan, K. Post, R. J. Crouch, and J. G. Levin. 1995. Defects in primer-template binding, processive DNA synthesis, and RNase H activity associated with chimeric reverse transcriptases having the murine leukemia virus polymerase domain joined to Escherichia coli RNase H. Biochemistry 34:5018-5029.
30. Gurgo, C., H.-G. Guo, G. Franchini, A. Aldovini, E. Collalti, K. Farrell, F. Wong-Staal, R. C. Gallo, and M. S. Reitz, Jr. 1988. Envelope sequences of two new United States HIV-1 isolates. Virology 164:531-536.
31. Henderson, L. E., M. A. Bowers, R. C. Sowder II, S. A. Serabyn, D. G. Johnson, J. W. Bess, Jr., L. O. Arthur, D. K. Bryant, and C. Fenselau. 1992. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences. J. Virol. 66:1856-1865.
32. Herschlag, D. 1995. RNA chaperones and the RNA folding problem. J. Biol. Chem. 270:20871-20874.
33. Herschlag, D., M. Khosla, Z. Tsuchihashi, and R. L. Karpel. 1994. An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis. EMBO J. 13:2913-2924.
34. Jamjoom, G. A., R. B. Naso, and R. B. Arlinghaus. 1976. Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D. J. Virol. 19: 1054-1072.
35. Jencks, W. P. 1969. Catalysis in chemistry and enzymology. McGraw-Hill, New York, N.Y.
36. Ji, X., G. J. Klarmann, and B. D. Preston. 1996. Effect of human immunodeficiency virus type 1 (HIV-1) nucleocapsid protein on HIV-1 reverse transcriptase activity in vitro. Biochemistry 35:132-143.
37. Kamitori, S., and F. Takusagawa. 1992. Crystal structure of the 2:1 complex between d(GAAGCTTC) and the anticancer drug actinomycin D. J. Mol. Biol. 225:445-456.
38. Karpel, R. L., L. E. Henderson, and S. Oroszlan. 1987. Interactions of retroviral structural proteins with single-stranded nucleic acids. J. Biol. Chem. 262:4961-4967.
39. Khan, R., and D. P. Giedroc. 1992. Recombinant human immunodeficiency virus type I nucleocapsid (NCp7) protein unwinds tRNA. J. Biol. Chem. 267:6689-6695.
40. Kim, J. K., C. Palaniappan, W. Wu, P. J. Fay, and R. A. Bambara. 1997. Evidence for a unique mechanism of strand transfer from the transactivation response region of HIV-1. J. Biol. Chem. 272:16769-16777.
41. 40a. Lapadat-Tapolsky, M., H. De Rocquigny, D. Van Gent, B. Roques, R. Plasterk, and J.-L. Darlix. 1993. Interactions between HIV-1 nucleocapsid protein and viral DNA may have important functions in the viral life cycle. Nucleic Acids Res. 21:831-839.
42. Lapadat-Tapolsky, M., C. Gabus, M. Rau, and J.-L. Darlix. 1997. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. J. Mol. Biol. 268:250-260.
43. Levin, J. G., P. M. Grimley, J. M. Ramseur, and I. K. Berezesky. 1974. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J. Virol. 14:152-161.
44. Levin, J. G., and M. J. Rosenak. 1976. Synthesis of murine leukemia virus proteins associated with virions assembled in actinomycin D-treated cells: evidence for persistence of viral messenger RNA. Proc. Natl. Acad. Sci. USA 73:1154-1158.
45. Levin, J. G., and J. G. Seidman. 1979. Selective packaging of host tRNAs by murine leukemia virus particles does not require genomic RNA. J. Virol. 29:328-335.
46. Lewis, J. L., Jr. 1972. Chemotherapy of gestational choriocarcinoma. Cancer 30:1517-1521.
47. 3 in vitro: studies of viral RNA molecules mutated in regions that flank the primer binding site. J. Virol. 70:4996-5004.
48. Manly, K. F., D. F. Smoler, E. Bromfeld, and D. Baltimore. 1971. Forms of deoxyribonucleic acid produced by virions of the ribonucleic acid tumor viruses. J. Virol. 7:106-111.
49. McDonnell, J. P., A.-C. Garapin, W. E. Levinson, N. Quintrell, L. Fanshier, and J. M. Bishop. 1970. DNA polymerases of Rous sarcoma virus: delineation of two reactions with actinomycin. Nature 228:433-435.
50. Messer, L. I., K. M. Currey, B. J. O'Neill, J. V. Maizel, Jr., J. G. Levin, and B. I. Gerwin. 1985. Functional analysis of reverse transcription by a frame-shift pol mutant of murine leukemia virus. Virology 146:146-152.
51. Messer, L. I., J. G. Levin, and S. K. Chattopadhyay. 1981. Metabolism of viral RNA in murine leukemia virus-infected cells: evidence for differential stability of viral message and virion precursor RNA. J. Virol. 40:683-690.
52. Müller, G., B. Strack, J. Dannull, B. S. Sproat, A. Surovoy, G. Jung, and K. Moelling. 1994. Amino acid requirements of the nucleocapsid protein of HIV-1 for increasing catalytic activity of a Ki-ras ribozyme in vitro. J. Mol. Biol. 242:422-429.
53. Müller, W., and D. M. Crothers. 1968. Studies on the binding of actinomycin and related compounds to DNA. J. Mol. Biol. 35:251-290.
54. Novak, U., R. Friedrich, and K. Moelling. 1979. Elongation of DNA complementary to the 5′ end of the avian sarcoma virus genome by the virion-associated RNA-dependent DNA polymerase. J. Virol. 30:438-452.
55. Paskind, M. P., R. A. Weinberg, and D. Baltimore. 1975. Dependence of Moloney murine leukemia virus production on cell growth. Virology 67:242-248.
56. Peliska, J. A., S. Balasubramanian, D. P. Giedroc, and S. J. Benkovic. 1994. Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity. Biochemistry 33:13817-13823.
57. Post, K., J. Guo, E. Kalman, T. Uchida, R. J. Crouch, and J. G. Levin. 1993. A large deletion in the connection subdomain of murine leukemia virus reverse transcriptase or replacement of the RNase H domain with Escherichia coli RNase H results in altered polymerase and RNase H activities. Biochemistry 32:5508-5517.
58. Powell, M. D., and J. G. Levin. 1996. Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immunodeficiency virus type 1 polypurine tract. J. Virol. 70:5288-5296.
59. Reich, E., and I. H. Goldberg. 1964. Actinomycin and nucleic acid function. Prog. Nucleic Acid Res. Mol. Biol. 3:183-234.
60. 58a. Rein, A., L. E. Henderson, and J. G. Levin. Nucleic acid chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem. Sci., in press.
61. Rice, W. G., J. G. Supko, L. Malspeis, R. W. Buckheit, Jr., D. Clanton, M. Bu, L. Graham, C. A. Schaefler, J. A. Turpin, J. Domagala, R. Gogliotti, J. P. Bader, S. M. Halliday, L. Coren, R. C. Sowder II. L. O. Arthur, and L. E. Henderson. 1995. Inhibitors of HIV nucleocapsid protein zinc fingers as candidates for the treatment of AIDS. Science 270:1194-1197.
62. Rill, R. L., and K. H. Hecker. 1996. Sequence-specific actinomycin D binding to single-stranded DNA inhibits HIV reverse transcriptase and other polymerases. Biochemistry 35:3525-3533.
63. Rothenberg, E., D. Smotkin, D. Baltimore, and R. A. Weinberg. 1977. In vitro synthesis of infectious DNA of murine leukaemia virus. Nature 269:122-126.
64. Sobell, H. M., and S. C. Jain. 1972. Stereochemistry of actinomycin binding to DNA II. Detailed molecular model of actinomycin-DNA complex and its implications. J. Mol. Biol. 68:21-34.
65. Takusagawa, F., K. T. Takusagawa, R. G. Carlson, and R. F. Weaver. 1997. Selectivity of F8-actinomycin D for RNA:DNA hybrids and its anti-leukemia activity. Bioorg. Med. Chem. 5:1197-1207.
66. Telesnitsky, A., and S. P. Goff. 1993. Strong-stop strand transfer during reverse transcription, p. 49-83. In A. M. Skalka and S. P. Goff (ed.). Reverse transcriptase. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
67. Temin, H. M. 1963. The effects of actinomycin D on growth of Rous sarcoma virus in vitro. Virology 20:577-582.
68. Temin, H. M. 1964. The participation of DNA in Rous sarcoma virus production. Virology 23:486-494.
69. Temin, H. M. 1976. The DNA provirus hypothesis. The establishment and implications of RNA-directed DNA synthesis. Science 192:1075-1080.
70. Temin, H. M., and S. Mizutani. 1970. RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature 226:1211-1213.
71. Tsuchihashi, Z., and P. O. Brown. 1994. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 68:5863-5870.
72. Vigier, P. and A. Goldé. 1964. Effects of actinomycin D and of mitomycin C on the development of Rous sarcoma virus. Virology 23:511-519.
73. Wadkins, R. M., and T. M. Jovin. 1991. Actinomycin D and 7-aminoactinomycin D binding to single-stranded DNA. Biochemistry 30:9469-9478.
74. Wells, R. D., and J. E. Larson. 1970. Studies on the binding of actinomycin D to DNA and DNA model polymers. J. Mol. Biol. 49:319-342.
75. Wu, W., L. E. Henderson, T. D. Copeland, R. J. Gorelick, W. J. Bosche, A. Rein, and J. G. Levin. 1996. Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J. Virol. 70:7132-7142.
76. You, J. C., and C. S. McHenry. 1993. HIV nucleocapsid protein. Expression in Escherichia coli, purification, and characterization. J. Biol. Chem. 268: 16519-16527.
77. You, J. C., and C. S. McHenry. 1994. Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. J. Biol. Chem. 269:31491-31495.